{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T11:57:20Z","timestamp":1774267040457,"version":"3.50.1"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Motivation: The discovery of therapeutic targets is important for cancer treatment. Although dozens of targets have been used in cancer therapies, cancer remains a serious disease with a high mortality rate. Owing to the expansion of cancer-related data, we now have the opportunity to infer therapeutic targets using computational biology methods.<\/jats:p>\n               <jats:p>Results: Here, we describe a method, termed anticancer activity enrichment analysis, used to determine genes that could be used as therapeutic targets. The results show that these genes have high likelihoods of being developed into clinical targets (&amp;gt;60%). Combined with gene expression data, we predicted 50 candidate targets for lung cancer, of which 19 of the top 20 genes are targeted by approved drugs or drugs used in clinical trials. A hexokinase family member, hexokinase domain-containing protein 1 (HKDC1), is the only one of the top 20 genes that has not been targeted by either an approved drug or one being used in clinical trials. Further investigations indicate that HKDC1 is a novel potential therapeutic target for lung cancer.<\/jats:p>\n               <jats:p>Conclusion: We developed a protocol to identify potential therapeutic targets from heterogeneous data. We suggest that HKDC1 is a novel potential therapeutic target for lung cancer.<\/jats:p>\n               <jats:p>Contact: \u00a0huangjf@mail.kiz.ac.cn<\/jats:p>\n               <jats:p>Supplementary Information: \u00a0Supplementary data are available at Bioinformatics online.<\/jats:p>","DOI":"10.1093\/bioinformatics\/btt606","type":"journal-article","created":{"date-parts":[[2013,10,26]],"date-time":"2013-10-26T00:23:57Z","timestamp":1382747037000},"page":"748-752","source":"Crossref","is-referenced-by-count":41,"title":["Inferring therapeutic targets from heterogeneous data: HKDC1 is a novel potential therapeutic target for cancer"],"prefix":"10.1093","volume":"30","author":[{"given":"Gong-Hua","family":"Li","sequence":"first","affiliation":[{"name":"1 State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences and 2Kunming Institute of Zoology, Chinese University of Hongkong Joint Research Center for Bio-resources and Human Disease Mechanisms, Kunming, Yunnan 650223, China"}]},{"given":"Jing-Fei","family":"Huang","sequence":"additional","affiliation":[{"name":"1 State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences and 2Kunming Institute of Zoology, Chinese University of Hongkong Joint Research Center for Bio-resources and Human Disease Mechanisms, Kunming, Yunnan 650223, China"},{"name":"1 State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences and 2Kunming Institute of Zoology, Chinese University of Hongkong Joint Research Center for Bio-resources and Human Disease Mechanisms, Kunming, Yunnan 650223, China"}]}],"member":"286","published-online":{"date-parts":[[2013,10,24]]},"reference":[{"key":"2023012710442609200_btt606-B1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nrd3186","article-title":"Targeted cancer therapies","volume":"9","author":"Aggarwal","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"2023012710442609200_btt606-B2","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1056\/NEJMra0707704","article-title":"Drug therapy: EGFR antagonists in cancer treatment","volume":"358","author":"Ciardiello","year":"2008","journal-title":"N. Eng. J. Med."},{"key":"2023012710442609200_btt606-B3","doi-asserted-by":"crossref","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","article-title":"ChEMBL: a large-scale bioactivity database for drug discovery","volume":"40","author":"Gaulton","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"2023012710442609200_btt606-B4","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/CCO.0b013e32835b651e","article-title":"Targeting the hallmarks of cancer: towards a rational approach to next-generation cancer therapy., Cur","volume":"25","author":"Hainaut","year":"2013","journal-title":"Opin. Oncol."},{"key":"2023012710442609200_btt606-B5","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"2023012710442609200_btt606-B6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang","year":"2009","journal-title":"Nat. Protoc."},{"key":"2023012710442609200_btt606-B7","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/bioinformatics\/bts084","article-title":"RNA-Seq Atlas-a reference database for gene expression profiling in normal tissue by next-generation sequencing","volume":"28","author":"Krupp","year":"2012","journal-title":"Bioinformatics"},{"key":"2023012710442609200_btt606-B8","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1093\/bioinformatics\/bts625","article-title":"CDRUG: a web server for predicting anticancer activity of chemical compounds","volume":"28","author":"Li","year":"2012","journal-title":"Bioinformatics"},{"key":"2023012710442609200_btt606-B9","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nmeth.1226","article-title":"Mapping and quantifying mammalian transcriptomes by RNA-Seq","volume":"5","author":"Mortazavi","year":"2008","journal-title":"Nat. Methods"},{"key":"2023012710442609200_btt606-B10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature04687","article-title":"A loss-of-function RNA interference screen for molecular targets in cancer","volume":"441","author":"Ngo","year":"2006","journal-title":"Nature"},{"key":"2023012710442609200_btt606-B11","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1158\/0008-5472.CAN-12-1370","article-title":"CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set","volume":"72","author":"Reinhold","year":"2012","journal-title":"Cancer Res."},{"key":"2023012710442609200_btt606-B12","first-page":"2468","article-title":"Glucose catabolism in cancer cells: amplification of the gene encoding type II hexokinase","volume":"56","author":"Rempel","year":"1996","journal-title":"Cancer Res."},{"key":"2023012710442609200_btt606-B13","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/nature03095","article-title":"Targeted cancer therapy","volume":"432","author":"Sawyers","year":"2004","journal-title":"Nature"},{"key":"2023012710442609200_btt606-B14","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1101\/gr.145144.112","article-title":"The transcriptional landscape and mutational profile of lung adenocarcinoma","volume":"22","author":"Seo","year":"2012","journal-title":"Genome Res."},{"key":"2023012710442609200_btt606-B15","doi-asserted-by":"crossref","first-page":"e47086B","DOI":"10.1371\/journal.pone.0047086","article-title":"An RNA interference lethality screen of the human druggable genome to identify molecular vulnerabilities in epithelial ovarian cancer","volume":"7","author":"Sethi","year":"2012","journal-title":"PLoS One"},{"key":"2023012710442609200_btt606-B16","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nrc1951","article-title":"The NCI60 human tumour cell line anticancer drug screen","volume":"6","author":"Shoemaker","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"2023012710442609200_btt606-B17","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1093\/nar\/gkl404","article-title":"Sequence biases in large scale gene expression profiling data","volume":"34","author":"Siddiqui","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"2023012710442609200_btt606-B18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J. Clin."},{"key":"2023012710442609200_btt606-B19","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrc2817","article-title":"Targeting metabolic transformation for cancer therapy","volume":"10","author":"Tennant","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"2023012710442609200_btt606-B20","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1158\/0008-5472.CAN-11-2781","article-title":"Identification of molecular vulnerabilities in human multiple myeloma cells by RNA interference lethality screening of the druggable genome","volume":"72","author":"Tiedemann","year":"2012","journal-title":"Cancer Res."},{"key":"2023012710442609200_btt606-B21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.mam.2011.04.004","article-title":"Vascular endothelial growth factors and receptors: anti-angiogenic therapy in the treatment of cancer","volume":"32","author":"Tugues","year":"2011","journal-title":"Mol. Aspects Med."},{"key":"2023012710442609200_btt606-B22","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1242\/jeb.00241","article-title":"Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function","volume":"206","author":"Wilson","year":"2003","journal-title":"J. Exp. Biol."},{"key":"2023012710442609200_btt606-B23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1084\/jem.20101470","article-title":"Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme","volume":"208","author":"Wolf","year":"2011","journal-title":"J. Exp. Med."}],"container-title":["Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/30\/6\/748\/48921452\/bioinformatics_30_6_748.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/30\/6\/748\/48921452\/bioinformatics_30_6_748.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T11:05:50Z","timestamp":1674817550000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article\/30\/6\/748\/285604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,24]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,3,15]]}},"URL":"https:\/\/doi.org\/10.1093\/bioinformatics\/btt606","relation":{},"ISSN":["1367-4811","1367-4803"],"issn-type":[{"value":"1367-4811","type":"electronic"},{"value":"1367-4803","type":"print"}],"subject":[],"published-other":{"date-parts":[[2014,3,15]]},"published":{"date-parts":[[2013,10,24]]}}}